NK521 Cell Injection: Clinical Trials

2 trials of NK521 Cell Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Not yet recruiting 1, Recruiting 1

Follow NK521 Cell Injection: new trials by email Literature Review of NK521 Cell Injection trials Research Report on NK521 Cell Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NK521 in the Treatment of Advanced Solid Tumors
NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer
Early Phase 1Not yet recruitingBase Therapeutics (Shanghai) Co., Ltd.182027-01-012026-09-30
NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors
NK521 Cell Injection - Advanced Solid Tumors
Early Phase 1RecruitingBase Therapeutics (Shanghai) Co., Ltd.182026-03-092026-05-01

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Ovarian Neoplasms (1)

Sponsors

Base Therapeutics (Shanghai) Co., Ltd. (2)

Countries

China (2)